422 related articles for article (PubMed ID: 29224132)
1. Treatment of mild-to-moderate hypoglycemia in patients with type 1 diabetes treated with insulin pump therapy: are current recommendations effective?
Gingras V; Desjardins K; Smaoui MR; Savard V; Messier V; Haidar A; Legault L; Rabasa-Lhoret R
Acta Diabetol; 2018 Mar; 55(3):227-231. PubMed ID: 29224132
[TBL] [Abstract][Full Text] [Related]
2. Timing of insulin basal rate reduction to reduce hypoglycemia during late post-prandial exercise in adults with type 1 diabetes using insulin pump therapy: A randomized crossover trial.
Roy-Fleming A; Taleb N; Messier V; Suppère C; Cameli C; Elbekri S; Smaoui MR; Ladouceur M; Legault L; Rabasa-Lhoret R
Diabetes Metab; 2019 Jun; 45(3):294-300. PubMed ID: 30165156
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
[TBL] [Abstract][Full Text] [Related]
4. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
[TBL] [Abstract][Full Text] [Related]
5. The Effects of Basal Insulin Suspension at the Start of Exercise on Blood Glucose Levels During Continuous Versus Circuit-Based Exercise in Individuals with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion.
Zaharieva D; Yavelberg L; Jamnik V; Cinar A; Turksoy K; Riddell MC
Diabetes Technol Ther; 2017 Jun; 19(6):370-378. PubMed ID: 28613947
[TBL] [Abstract][Full Text] [Related]
6. Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study.
Franc S; Daoudi A; Pochat A; Petit MH; Randazzo C; Petit C; Duclos M; Penfornis A; Pussard E; Not D; Heyman E; Koukoui F; Simon C; Charpentier G
Diabetes Obes Metab; 2015 Dec; 17(12):1150-7. PubMed ID: 26264812
[TBL] [Abstract][Full Text] [Related]
7. Weight-based carbohydrate treatment of hypoglycaemia in people with Type 1 diabetes using insulin pump therapy: a randomized crossover clinical trial.
McTavish L; Corley B; Weatherall M; Wiltshire E; Krebs JD
Diabet Med; 2018 Mar; 35(3):339-346. PubMed ID: 29285796
[TBL] [Abstract][Full Text] [Related]
8. Effects of Preceding Ethanol Intake on Glucose Response to Low-Dose Glucagon in Individuals With Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover Study.
Ranjan A; Nørgaard K; Tetzschner R; Steineck IIK; Clausen TR; Holst JJ; Madsbad S; Schmidt S
Diabetes Care; 2018 Apr; 41(4):797-806. PubMed ID: 29358493
[TBL] [Abstract][Full Text] [Related]
9. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
[TBL] [Abstract][Full Text] [Related]
10. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Efficacy and Safety of Sensor Augmented Insulin Pump Therapy with Low-Glucose Suspend Feature in Patients with Type 1 Diabetes.
Gómez AM; Marín Carrillo LF; Muñoz Velandia OM; Rondón Sepúlveda MA; Arévalo Correa CM; Mora Garzón E; Cuervo Diaz MC; Henao Carrillo DC
Diabetes Technol Ther; 2017 Feb; 19(2):109-114. PubMed ID: 28001445
[TBL] [Abstract][Full Text] [Related]
12. Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.
Ranjan A; Wendt SL; Schmidt S; Madsbad S; Holst JJ; Madsen H; Knudsen CB; Jørgensen JB; Nørgaard K
Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):322-330. PubMed ID: 28922582
[TBL] [Abstract][Full Text] [Related]
13. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.
Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW
JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010
[TBL] [Abstract][Full Text] [Related]
14. Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes.
Ranjan A; Schmidt S; Madsbad S; Holst JJ; Nørgaard K
Diabetes Obes Metab; 2016 Apr; 18(4):410-8. PubMed ID: 26743775
[TBL] [Abstract][Full Text] [Related]
15. Lower versus standard sucrose dose for treating hypoglycemia in patients with type 1 diabetes mellitus in therapy with predictive low glucose suspend (PLGS) augmented insulin pumps: A randomized crossover trial in Santiago, Chile.
Grassi B; Onetto MT; Zapata Y; Jofré P; Echeverría G
Diabetes Metab Syndr; 2021; 15(3):695-701. PubMed ID: 33813244
[TBL] [Abstract][Full Text] [Related]
16. Prevention of Insulin-Induced Hypoglycemia in Type 1 Diabetes with Predictive Low Glucose Management System.
Abraham MB; de Bock M; Paramalingam N; O'Grady MJ; Ly TT; George C; Roy A; Spital G; Karula S; Heels K; Gebert R; Fairchild JM; King BR; Ambler GR; Cameron F; Davis EA; Jones TW
Diabetes Technol Ther; 2016 Jul; 18(7):436-43. PubMed ID: 27148807
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of Automated Insulin Suspension and Glucose Responses with the Predictive Low-Glucose Management System.
Abraham MB; Smith GJ; Nicholas JA; Fairchild JM; King BR; Ambler GR; Cameron FJ; Davis EA; Jones TW;
Diabetes Technol Ther; 2019 Jan; 21(1):28-34. PubMed ID: 30585769
[TBL] [Abstract][Full Text] [Related]
18. Reduction in Hypoglycemia With the Predictive Low-Glucose Management System: A Long-term Randomized Controlled Trial in Adolescents With Type 1 Diabetes.
Abraham MB; Nicholas JA; Smith GJ; Fairchild JM; King BR; Ambler GR; Cameron FJ; Davis EA; Jones TW;
Diabetes Care; 2018 Feb; 41(2):303-310. PubMed ID: 29191844
[TBL] [Abstract][Full Text] [Related]
19. Insulin pump use compared with intravenous insulin during labour and delivery: the INSPIRED observational cohort study.
Drever E; Tomlinson G; Bai AD; Feig DS
Diabet Med; 2016 Sep; 33(9):1253-9. PubMed ID: 26927202
[TBL] [Abstract][Full Text] [Related]
20. Clinical factors affecting the perception of hypoglycemia in type 1 diabetes patients treated with personal insulin pumps.
Matejko B; Grzanka M; Kieć-Wilk B; Małecki MT; Klupa T
Ann Agric Environ Med; 2013; 20(1):152-4. PubMed ID: 23540230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]